News from CEPTON Strategies

News and publications

Discover our latest publications and the press articles

CEPTON is a renowned strategy consulting firm in its areas of expertise such as Pharma, Medtech & Healthcare Services. Being both authors and subjects of various publications in our partners’ fields of expertise, CEPTON is often covered by the specialized press.

Why Managed Access Programs should be a key component of your strategy for Europe

Posted on 14.12.2017 by Marc-Olivier Bévierre

See more

11 things innovative healthcare firms must know when planning to launch in Europe

Posted on 07.12.2017 by Marc-Olivier Bévierre

See more

The future of IVDs: important regulatory changes will soon redistribute the cards in the EU

Posted on 01.12.2017 by Marc-Olivier Bévierre

See more

European reform: the changes to expect for class IIb and class III medical devices

Posted on 27.11.2017 by Marc-Olivier Bévierre

See more

How will Brexit affect the strategies of US biotechs?

Posted on 20.11.2017 by Marc-Olivier Bévierre

See more

European biosimilar market: a tremendous opportunity with variable market access constraints

Posted on 14.11.2017 by Marc-Olivier Bévierre

See more

Gene therapy: the trap of biomanufacturing

Posted on 07.10.2017 by Marc-Olivier Bévierre

See more